JOSEF Z ABBO

Allopathic & Osteopathic Physicians|Family Medicine LAS VEGAS, NV NPI 1104016872

General Payments — all program years on this page

$1,822.90

  • Category: General Payments
  • Program years: PY2018–2023
  • Record count: 83
  • As of (CMS publication): 2026-01-23

Latest program year (PY2023): $340.97 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2023) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $340.9717

By paying entity

Latest program year (PY2023) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $38.312
2020 $224.3011
2021 $471.9326
2022 $747.3927
2023 $340.9717

Records — PY2023 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1002088509 GlaxoSmithKline, LLC. $24.56 09/11/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002558417 Novo Nordisk Inc $16.13 04/04/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002558429 Novo Nordisk Inc $18.49 02/14/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1002558441 Novo Nordisk Inc $24.63 02/01/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1014162719 Otsuka America Pharmaceutical, Inc. $21.29 04/12/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1014162727 Otsuka America Pharmaceutical, Inc. $22.61 08/17/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1014474734 AstraZeneca Pharmaceuticals LP $14.30 02/06/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1020608187 Amgen Inc. $18.38 09/11/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1031641711 Lilly USA, LLC $13.64 03/13/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1034237835 IDORSIA PHARMACEUTICALS US INC $13.90 05/11/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1040444675 ITI, Inc. $23.77 04/06/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1049272717 PFIZER INC. $18.69 05/03/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1050850047 Corcept Therapeutics $21.15 05/08/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1051516757 Vanda Pharmaceuticals Inc. $24.49 03/02/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1056250709 MannKind Corporation $18.27 05/04/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
987871019 Janssen Pharmaceuticals, Inc $29.70 01/25/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
996824129 Boehringer Ingelheim Pharmaceuticals, Inc. $16.97 09/18/2023 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.